[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rennova Health Inc (RNVAD)

Rennova Health Inc (RNVAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rennova Health Inc 400 S. Australian Avenue Suite 800 West Palm Beach FL 33401 USA

www.rennovahealth.com P: 561-855-1626

Sector:

Medical

INDUSTRY GROUPING:

Medical Information Systems

Description:

Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Company's solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.

Key Statistics

Overview:

Market Capitalization, $K 318,791
Shares Outstanding, K 44,276,552
Float, K 19,694,210
% Float 44.48%
% of Insider Shareholders 55.52%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 7,200 K
Annual Net Income, $ -18,340 K

Growth:

1-Year Return -100.00%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth -60.85%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.59 on 11/15/21
Next Earnings Date 06/13/22
Earnings Per Share ttm -234.37
EPS Growth vs. Prev Qtr 95.72%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10000 on 03/16/22

RNVAD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -254.72%
Debt/Equity 0.00
Price/Sales 247.12
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -0.93
60-Month Beta 18.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.